You are here

Article info

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-1112-ESGO MFAP5 is related to ovarian cancer progression but not suitable as prognostic biomarker
Free

Authors

  • Katarzyna Aleksandra Kujawa 1Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska – Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland PubMed articlesGoogle scholar articles
  • Ewa Zembala-Nożyńska Tumor Pathology Department, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland PubMed articlesGoogle scholar articles
  • Joanna Syrkis Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland PubMed articlesGoogle scholar articles
  • Alexander Jorge Cortez Department of Biostatistics and Bioinformatics, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland PubMed articlesGoogle scholar articles
  • Jolanta Kupryjańczyk Tumor Pathology Department, Maria Skłodowska-Curie National Research Institute of Oncology, Warszawa, Poland PubMed articlesGoogle scholar articles
  • Katarzyna Marta Lisowska Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland PubMed articlesGoogle scholar articles

Citation

Kujawa KA, Zembala-Nożyńska E, Syrkis J, et al
2022-RA-1112-ESGO MFAP5 is related to ovarian cancer progression but not suitable as prognostic biomarker
International Journal of Gynecologic Cancer 2022;32:A301.

Publication history

  • First published October 20, 2022.
Online issue publication 
October 27, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.